1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66B4382A5FDD45E580025886B002B85F2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/developing-best-hybrid-work-model-for-medical-affairs-organization?opendocument
18
19opendocument
2098.80.143.34
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Structure, Staffing and Budgets

Developing the Best Hybrid Work Model for Your Medical Affairs Organization

ID: POP-350


Features:

22 Info Graphics

33 Data Graphics

700+ Metrics


Pages: 67


Published: 2022


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
With the pandemic now reaching a waning stage in most parts of the world, Medical Affairs leaders must determine what is the right hybrid model for their organizations: continue to work remotely, return to all in-person, or develop a flexible hybrid approach?

Best Practices, LLC undertook this benchmarking research to examine the changing forms, features, conditions, and triggers for hybrid work models that are best suited for a flexible and resilient Medical Affairs organization. This report probes and profiles how different medical organizations are using technology, shifting and shaping staff roles, adjusting remote vs. in-person work schedules, shrinking or expanding facilities, and planning post-pandemic.

Medical Affairs leaders can use to this report to develop a hybrid work model that is best suited for a flexible, effective, and resilient Medical Affairs organization.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Medical Device; Manufacturing; Biotech; Consumer Products; Diagnostic; Health Care; Communications; Clinical Research; Laboratories


Companies Profiled:
Alexion Pharmaceuticals; ASC Therapeutics; Asklepion Pharmaceuticals; LLC; AstraZeneca; Baxter Healthcare; Bayer; Bionorica SE; Boehringer Ingelheim; Cipla; Eisai; Elevation Oncology; Eli Lilly; Ferozsons Laboratories Limited; GE Healthcare; Grifols; Heron Therapeutics; Incyte; Ipsen; Jazz Pharmaceuticals; Kinnate Biopharma; Merck; Merz Aesthetics; NexGen Healthcare; Novartis; Novavax; OPEN Health; Orchard Therapeutics; OTSUKA; Pfizer; Roche; Sandoz; Sage Therapeutics; Sanofi; Santen; Servier; Supernus; Terumo BCT: Terumo Blood and Cell Technologies; Teva Pharmaceutical Industries Ltd; UCB Pharma

Study Snapshot

Best Practices, LLC engaged 51 Medical leaders from 39 companies in this benchmarking research.

Key topics covered in this report include:

  • Types of Medical Affairs Work Models
  • Activities & Staffing in Successful Hybrid Models
  • Effective KPIs for Measuring the Impact of Remote Work in Medical Affairs
  • Hybrid Model for Field Medical Interactions
  • Key Decisions, Advantages and Barriers to Hybrid Model Success
  • Lessons Learned for Successfully Leading in a Hybrid Medical Affairs World

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • “Remote-friendly” vs. “In-office preferred”: 46% of orgs have embraced a “permanent commitment” to a remote option.
  • Activities: Most routine medical activities and meetings are well-suited to virtual. Team/relationship-building activities, KOL engagement, congresses, brainstorming / planning sessions work best in-person.

Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 4-11
II.
Hybrid Work Models in Medical AffairsPg. 12-16
III.
Activities & Staffing in Successful Hybrid ModelsPg. 17-29
IV.
Measuring PerformancePg. 30-35
V.
Delivering Value in Field MedicalPg. 36-41
VI.
Key Decisions, Benefits and Barriers to Hybrid Model SuccessPg. 42-49
VII.
Lessons LearnedPg. 50-59
VIII.
Appendix of Additional Benchmark DataPg. 60-63
IX.
Benchmark Study DemographicsPg. 64-66
X.
About Best Practices, LLCPg. 67

    List of Charts & Exhibits

    I. Executive Summary

    • Benchmark study partners
    • Defining the new Medical Affairs work models
    • Industry perspective on hybrid work
    • Greatest benefits and drawbacks of remote / hybrid work environments
    • Medical Affairs work mix during and post-pandemic
    • Relative merits of “Remote vs. In-office” work option preferences
    • Staffing evolution in Medical Affairs

    II. Types of Work Models

    • Time spent by Medical Affairs staff in each work venue (remote, company office, customer site / in field) during the pandemic
    • Time spent by Medical Affairs staff in each work venue post-pandemic
    • Leadership levels of “work from home” decision makers for each kind of Medical Affairs employee
    • Expected amount of time to be spent in office for medical team leaders vs. frontline staff and other team members

    III. Activities & Staffing in Successful Hybrid Models

    • Well-suited and poorly-suited Medical Affairs activities for being executed in a hybrid or virtual manner
    • Effectiveness of medical activities in terms of their suitability to be conducted in a virtual work environment where people connect remotely
    • Effectiveness of communication and education activities in terms of their suitability to be conducted in a virtual work environment where people connect remotely
    • Effectiveness of governance and planning activities in terms of their suitability to be conducted in a virtual work environment where people connect remotely
    • Effectiveness of evidence activities in terms of their suitability to be conducted in a virtual work environment where people connect remotely
    • Effectiveness of thought leaders and influencers activities in terms of their suitability to be conducted in a virtual work environment where people connect remotely
    • Medical Affairs activities that are best-suited to virtual execution
    • Medical Affairs activities that are worst-suited to virtual execution
    • Turnover rate experienced within different parts of Medical Affairs organization over the last two years
    • Effective tactics in evolving staffing needs to reflect the hybrid work environment of the workforce
    • Most influential factors in establishing the continuation of at least partial remote work
    • Changes sought in qualifications / experiences when hiring employees who will work in a hybrid model

    IV. Measuring Performance

    • Effective KPIs for measuring the impact of remote work
    • New KPI(s) that have best measured the impact of medical strategy and field medical engagement
    • New KPI(s) that have best measured the impact of scientific publication, medical information, and medical education
    • New KPI(s) that have best measured the impact of HEOR / RWE / data & insights, medical excellence, and medical operations
    • New KPI(s) that have best measured the impact of medical governance and training

    V. Delivering Value in Field Medical

    • Breakdown of MSL interactions with thought leaders during and post-pandemic
    • Average number of KOL interactions per month (whether virtual or face-to-face)
    • Projected number of new meetings per month, post-pandemic
    • Setting targets for in-person face-to-face meetings with thought leaders and important HCPs
    • Weighing MSL performance scorecards based on different interaction channels

    VI. Key Decisions, Benefits and Barriers to Hybrid Model Success

    • Effective facilities utilization tactics to accommodate hybrid and remote work during pandemic
    • Top lessons learned or best practices developed for using technology to enable effective remote work in a hybrid business model
    • Top three remote work benefits and barriers
    • Greatest benefits of remote / hybrid work environments for Medical Affairs organizations
    • Barriers / challenges to remote work for Medical Affairs organizations
    • Most notable lessons learned or best practices developed for effectively engaging and motivating employees who work in a remote work environment in hybrid business model
    • Future perspectives on hybrid work in Medical Affairs

    VII. Lessons Learned

    • Most notable lessons learned or best practices for making remote work environments and hybrid business model high functioning
    • Lessons for success
    • Lessons for successfully leading in a hybrid Medical Affairs world: Hybrid model opportunities
    • Lessons for successfully leading in a hybrid Medical Affairs world: Challenges
    • Lessons for successfully leading in a hybrid Medical Affairs world: Effective management practices
    • Lessons for successfully leading in a hybrid Medical Affairs world: Technology and digital enablement
    • Lessons for successfully leading in a hybrid Medical Affairs world: Staffing and talent considerations
    • Lessons for successfully leading in a hybrid Medical Affairs world: KPIs
    • Lessons for successfully leading in a hybrid Medical Affairs world: Field engagement